Company / R&D Expense
Fortress Biotech, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$56.6M
FY2025
5-year range
$56.6M / $134.9M
FY2021-FY2025
Trend
-44.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from -$30M in FY2016 to $135M in FY2023.
Based on SEC 10-K filings.
$57M in FY2025 with a 5-year CAGR of -7.0%.
Declined from $135M to $57M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -24.0%
- 5-Year CAGR
- -7.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -7.0%, indicating a declining trend.
- In FY2025, r&d expense decreased 44.3% year-over-year.
- Peak r&d expense was recorded in FY2023.
- Lowest r&d expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $56.6M | -44.3% |
| FY2024 | $101.7M | -24.6% |
| FY2023 | $134.9M | +4.7% |
| FY2022 | $128.9M | +101.0% |
| FY2021 | $64.1M | -21.2% |
| FY2020 | $81.3M | -6.9% |
| FY2019 | $87.4M | +80.8% |
| FY2018 | $48.3M | +62.1% |
| FY2017 | $29.8M | +200.0% |
| FY2016 | -$29.8M | -216.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026